Angiotensin Receptor Antagonists: all 1,097 studies that test it
Page 4 of 11. Open to participants first (76), then studies with results posted, then the rest; newest registration first within each.
- Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood PressureCompletedNCT00435162Phase 3Results posted
- Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and PlaceboCompletedNCT00434967Phase 3Results posted
- Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood PressureCompletedNCT00433836Phase 3Results posted
- Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential HypertensionCompletedNCT00430508Phase 3Results posted
- Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan SyndromeCompletedNCT00429364Phase 3Results posted
- Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential HypertensionCompletedNCT00425373Phase 2/3Results posted
- Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With HypertensionCompletedNCT00413413Phase 3Results posted
- An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With HypertensionCompletedNCT00412932Phase 4Results posted
- Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary SyndromeCompletedNCT00409578Phase 2Results posted
- An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II DiabetesCompletedNCT00403481Phase 4Results posted
- Treating the Endothelium to Restore Insulin SensitivityCompletedNCT00402194Not applicableResults posted
- Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive PatientsCompletedNCT00396656Phase 3Results posted
- Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs AloneCompletedNCT00391846Phase 4Results posted
- Irbesartan and Atenolol in Hypertensive Heart DiseaseCompletedNCT00389168Phase 2/3Results posted
- A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.CompletedNCT00386607Phase 3Results posted
- Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate HypertensionCompletedNCT00362115Phase 2Results posted
- Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)CompletedNCT00348686Phase 4Results posted
- Renoprotection in Early Diabetic Nephropathy in Pima IndiansCompletedNCT00340678Phase 3Results posted
- Obese Hypertension Study (0954-315)CompletedNCT00289887Phase 3Results posted
- HALT Progression of Polycystic Kidney Disease Study ACompletedNCT00283686Phase 3Results posted
- Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of HypertensionCompletedNCT00281580Phase 3Results posted
- Diabetic Retinopathy Candesartan TrialsCompletedNCT00252733Phase 3Results posted
- DIabetic Retinopathy Candesartan Trials.CompletedNCT00252720Phase 3Results posted
- DIabetic Retinopathy Candesartan TrialsCompletedNCT00252694Phase 3Results posted
- Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)CompletedNCT00249795Phase 3Results posted
- Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of AgeCompletedNCT00244621Phase 3Results posted
- Effect of Valsartan on Carotid Artery DiseaseCompletedNCT00208767Phase 2Results posted
- Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With HypertensionCompletedNCT00171054Phase 4Results posted
- Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.CompletedNCT00153101Phase 4Results posted
- Olmesartan Pediatric Pharmacokinetic (PK) StudyCompletedNCT00151814Phase 1Results posted
- Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood PressureCompletedNCT00151775Phase 2/3Results posted
- Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)CompletedNCT00149227Phase 4Results posted
- ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy TrialCompletedNCT00141453Phase 3Results posted
- Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose IntoleranceCompletedNCT00122447Not applicableResults posted
- Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular ComplicationsCompletedNCT00097786Phase 3Results posted
- Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)CompletedNCT00095238Phase 3Results posted
- Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)CompletedNCT00090259Phase 3Results posted
- Angiotensin II Blockade for Chronic Allograft NephropathyCompletedNCT00067990Phase 4Results posted
- Bioequivalence of a Generic Azilsartan Medoxomil Tablet Compared With the Reference Product (Edarbi®) in Healthy Chinese Volunteers Under Fasting and Fed ConditionsCompletedNCT07881263Phase 1
- Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/AllisartanCompletedNCT07704697Phase 3
- Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With AmlodipineCompletedNCT07704684Phase 3
- A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential HypertensionCompletedNCT07700875Phase 2
- Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive PopulationCompletedNCT07652567Not applicable
- Effectiveness of Valsartan Alone vs Combination Therapy in Hypertensive Heart DiseaseCompletedNCT07544888Phase 1
- The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEFCompletedNCT07417215Phase 4
- Sacubitril-valsartan in Patients With Heart Failure.CompletedNCT07341893Not applicable
- Comparing Bisoprolol and Valsartan-Amlodipine for HypertensionCompletedNCT07327749Phase 4
- The Effect of Losartan on CephalexinCompletedNCT07300670Phase 1
- Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental GlomerulosclerosisActive, not recruitingNCT07219121Phase 4
- Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart FailureCompletedNCT07023016Phase 2/3
- Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With HyperuricemiaCompletedNCT06718062Phase 4
- Losartan and Social ProcessingCompletedNCT06624904Early Phase 1
- Clinical Study Evaluating the Effect of LosartanCompletedNCT06539806Not applicable
- Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection FractionWithdrawnNCT06536309Phase 4
- Efficacy and Safety of HB-1 for Panic DisorderTerminatedNCT06483789Phase 2
- Detoxification From the Lipid TractCompletedNCT06357104Phase 4
- Losartan Use to Mitigate Arthrofibrosis Following Total Joint ArthroplastyWithdrawnNCT06333522Phase 4
- Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer PatientsCompletedNCT06135493Phase 2
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)CompletedNCT06112678Phase 1
- A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.CompletedNCT06063109Phase 1
- Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve RegurgitationCompletedNCT05991284Phase 4
- A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary HypercholesterolemiaCompletedNCT05930028Phase 3
- Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial HypertensionCompletedNCT05920005Phase 3
- Sacubitril/Valsartan Versus Valsartan in Heart FailureCompletedNCT05881720Phase 4
- A Study to Evaluate the Efficacy and Safety of BR1015 Combination TherapyCompletedNCT05878561Phase 3
- GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic CancerWithdrawnNCT05861336Phase 2
- Losartan and MemoryCompletedNCT05828940Not applicable
- Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney DiseaseCompletedNCT05759754Not applicable
- Azilsartan in Patients With Diabetic Kidney Disease and HypertensionStatus unknownNCT05753696Not applicable
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)CompletedNCT05749861Phase 1
- Diabetic Autonomic Neuropathy and Left Ventricular FunctionCompletedNCT05713396Phase 4
- Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy VolunteersCompletedNCT05688098Phase 1
- Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.CompletedNCT05681273Phase 1
- Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy VolunteersCompletedNCT05663073Phase 1
- Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer PatientsActive, not recruitingNCT05637216Phase 2
- ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)Active, not recruitingNCT05630612Phase 2
- Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19Active, not recruitingNCT05619653Phase 3
- Losartan in Prevention of Radiation-Induced Heart FailureCompletedNCT05607017Early Phase 1
- " Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "Status unknownNCT05580510Phase 2/3
- Study to Evaluate the Pharmacokinetics of Oral Sparsentan SuspensionCompletedNCT05562362Phase 1
- Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348CompletedNCT05549401Phase 1
- Effects and Safety of Sacubitril/Valsartan on Refractory HypertensionStatus unknownNCT05545059Phase 3
- Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial FibrillationCompletedNCT05528419Phase 4
- Angiotensin-Neprilysin Inhibition in Hemodialysis InitiationCompletedNCT05498181Phase 2
- Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension PatientsCompletedNCT05475665Phase 3
- Losartan and Uric Acid Metabolism in Children With Proteinuric NephropathiesCompletedNCT05402397Phase 4
- Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection FractionCompletedNCT05387967Phase 4
- Hypertension in Young Adults TrialTerminatedNCT05370599Phase 2
- Lifestyle and Pharmacological Interventions in Hypertrophic CardiomyopathyCompletedNCT05366101Phase 2/3
- PHL Treatment in Pancreatic CancerActive, not recruitingNCT05365893Early Phase 1
- Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential HypertensionCompletedNCT05359068Phase 3
- Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)Active, not recruitingNCT05331144Phase 2
- Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)CompletedNCT05322889Phase 2
- A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese SubjectsStatus unknownNCT05297929Phase 1
- Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin IIStatus unknownNCT05269615Phase 4
- Sacubitril/Valsartan for CKD5 Stage Dialysis PatientsCompletedNCT05243199Phase 4
- The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant RecipientsCompletedNCT05232370Phase 2
- A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult VolunteersStatus unknownNCT05223101Phase 1
- Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARBStatus unknownNCT05212597Phase 2
- A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)CompletedNCT05192356Phase 1